首页> 外文期刊>Drugs of today: Medicamentos de actualidad >A report from the 21st European Congress of Clinical Microbiology and Infectious Diseases and the 27th International Congress of Chemotherapy (May 7-10, 2011 - Milan, Italy).
【24h】

A report from the 21st European Congress of Clinical Microbiology and Infectious Diseases and the 27th International Congress of Chemotherapy (May 7-10, 2011 - Milan, Italy).

机译:第21届欧洲临床微生物学和传染病大会和第27届国际化学疗法大会的报告(2011年5月7日至10日,意大利米兰)。

获取原文
获取原文并翻译 | 示例
           

摘要

Multidrug resistance and superbugs are becoming increasingly troublesome around the world, with more and more cases of resistant pathogens being described,resulting in increased human suffering, an increased likelihood for adverse outcomes and increased treatment and management costs. This was clearly corroborated during this year's European Congress of Clinical Microbiology and infectious Diseases (ECCMID) meeting, with resistance, and corresponding poorer outcomes, reported of Staphylococcus aureus to methicillin.
机译:在世界范围内,多药耐药性和超级细菌的麻烦日益严重,描述了越来越多的耐药病原体病例,导致人类痛苦增加,不良后果的可能性增加以及治疗和管理成本的增加。据报道,金黄色葡萄球菌对甲氧西林的耐药性和相应的较差结果在今年的欧洲临床微生物学和传染病大会(ECCMID)会议上得到了证实。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号